NuCana is a biopharmaceutical company focused on developing cancer treatments using its own technology, ProTide. Their product candidate, Acelarin, is undergoing Phase I and II clinical trials for various cancers. The company is also working on developing NUC-3373 and NUC-7738 for the treatment of cancer.